Viewing StudyNCT04572165



Ignite Creation Date: 2024-05-06 @ 3:15 PM
Last Modification Date: 2024-10-26 @ 1:46 PM
Study NCT ID: NCT04572165
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-01-02
First Post: 2020-09-30

Brief Title: Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Sponsor: Novo Nordisk AS
Organization: Novo Nordisk AS

Organization Data

Organization: Novo Nordisk AS
Class: INDUSTRY
Study ID: NN9535-4447
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novo Nordisk AS
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Department of Public Health University of Southern Denmark UNKNOWN